tailieunhanh - Common mental health disorders - Identification and pathways to care

On behalf of the Mental Health Commission of Canada, we are extremely pleased to present this document to everyone across the country who has been directly or indirectly touched by a mental health problem or illness, and to everyone concerned with mental health issues. We believe that this in fact describes just about every single person living in Canada. It has often been – rightly – said that there is no health without mental health. For far too long, this simple truth has been obscured by the lack of public discussion of mental health issues. Despite important progress in recent years,. | NHS National Institute for Health and Clinical Excellence Identification and pathways to care Common mental health disorders Issue date May 2011 NICE clinical guideline 123 Developed by the National Collaborating Centre for Mental Health NICE clinical guideline 123 Common mental health disorders identification and pathways to care Ordering information You can download the following documents from guidance CG123 The NICE guideline this document - all the recommendations. A quick reference guide - a summary of the recommendations for healthcare professionals. Understanding NICE guidance - a summary for patients and carers. The full guideline - all the recommendations details of how they were developed and reviews of the evidence they were based on. For printed copies of the quick reference guide or Understanding NICE guidance phone NICE publications on 0845 003 7783 or email publications@ and quote N2541 quick reference guide N2542 Understanding Nice guidance . NICE clinical guidelines are recommendations about the treatment and care of people with specific diseases and conditions in the NHS in England and Wales. This guidance represents the view of NICE which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient in consultation with the patient and or guardian or carer and informed by the summary of product characteristics of any drugs they are considering. Implementation of this guidance is the responsibility of local commissioners and or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance in their local context in light of their duties to avoid unlawful discrimination and to have regard